Charles Schwab Investment Management Inc Emergent Bio Solutions Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,224,727 shares of EBS stock, worth $19.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,224,727

Previous 3,166,246 29.74%

Holding current value

$19.8 Million

Previous $21.6 Million 13.97%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$5.72 - $14.77 $5.39 Million - $13.9 Million	-941,519 Reduced 29.74%	2,224,727 $18.6 Million
Q2 2024 Aug 12, 2024	SELL	$1.86 - $6.98 $1.83 Million - $6.88 Million	-985,073 Reduced 23.73%	3,166,246 $21.6 Million
Q1 2024 May 08, 2024	BUY	$1.5 - $3.41 $1.92 Million - $4.36 Million	1,277,335 Added 44.44%	4,151,319 $10.5 Million
Q4 2023 Feb 06, 2024	BUY	$1.82 - $3.16 $2.39 Million - $4.15 Million	1,312,934 Added 84.11%	2,873,984 $6.9 Million
Q3 2023 Nov 08, 2023	BUY	$3.17 - $7.91 $1.53 Million - $3.82 Million	482,632 Added 44.75%	1,561,050 $5.31 Million
Q2 2023 Aug 09, 2023	BUY	$7.35 - $13.21 $1.89 Million - $3.4 Million	257,198 Added 31.32%	1,078,418 $7.93 Million
Q1 2023 May 11, 2023	BUY	$7.79 - $16.29 $1 Million - $2.09 Million	128,384 Added 18.53%	821,220 $8.51 Million
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $1.42 Million - $2.77 Million	129,035 Added 22.89%	692,836 $8.18 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $1.17 Million - $2.08 Million	58,155 Added 11.5%	563,801 $11.8 Million
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $489,940 - $779,580	17,868 Added 3.66%	505,646 $15.7 Million
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $660,762 - $945,860	18,113 Added 3.86%	487,778 $20 Million
Q4 2021 Feb 11, 2022	BUY	$33.11 - $55.01 $529,958 - $880,490	16,006 Added 3.53%	469,665 $20.4 Million
Q3 2021 Nov 16, 2021	SELL	$50.07 - $66.05 $4.17 Million - $5.5 Million	-83,282 Reduced 15.51%	453,659 $22.7 Million
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $1.29 Million - $1.83 Million	22,711 Added 4.42%	536,941 $33.8 Million
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $7.4 Million - $10.7 Million	-85,856 Reduced 14.31%	514,230 $47.8 Million
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $619,584 - $872,364	-7,826 Reduced 1.29%	600,086 $53.8 Million
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $11.6 Million - $19.1 Million	141,726 Added 30.4%	607,912 $62.8 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $2.12 Million - $3.5 Million	-39,083 Reduced 7.74%	466,186 $36.9 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $276,748 - $385,674	5,609 Added 1.12%	505,269 $29.2 Million
Q4 2019 Feb 07, 2020	BUY	$51.21 - $59.06 $1.11 Million - $1.28 Million	21,637 Added 4.53%	499,660 $27 Million
Q3 2019 Nov 08, 2019	SELL	$40.6 - $57.2 $106,290 - $149,749	-2,618 Reduced 0.54%	478,023 $25 Million
Q2 2019 Aug 09, 2019	SELL	$39.92 - $53.86 $253,132 - $341,526	-6,341 Reduced 1.3%	480,641 $23.2 Million
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $2.45 Million - $3.36 Million	50,728 Added 11.63%	486,982 $24.6 Million
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $1.29 Million - $1.69 Million	-23,130 Reduced 5.04%	436,254 $25.9 Million
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $1.15 Million - $1.47 Million	22,141 Added 5.06%	459,384 $30.2 Million
Q2 2018 Aug 08, 2018	SELL	$48.33 - $55.64 $451,788 - $520,122	-9,348 Reduced 2.09%	437,243 $22.1 Million
Q1 2018 May 07, 2018	SELL	$44.44 - $54.39 $1.24 Million - $1.52 Million	-27,887 Reduced 5.88%	446,591 $23.5 Million
Q4 2017 Jan 17, 2018	SELL	$37.77 - $47.75 $5.41 Million - $6.84 Million	-143,345 Reduced 23.2%	474,478 $22 Million
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $21.1 Million - $25 Million	617,823	617,823 $25 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $443M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Emergent Bio Solutions Inc. Transaction History